查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1525968

乳癌復发评分测试市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2033年

Breast Recurrence Score Test Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 233 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球乳癌復发评分测试市场的综合报告。本报告全面评估了主要市场动态，包括驱动因素、趋势、机会和挑战，并提供了有关市场结构的详细见解。

关键见解

  • 乳癌復发评分测试市场规模（2024年）：2.59 亿美元
  • 市场预测金额（2033年）：5.766 亿美元
  • 全球市场成长率（2024年至2033年年复合成长率）：9.3%

乳癌復发评分测试市场：调查范围

乳癌復发评分测试提供基于肿瘤组织基因图谱的个人化风险评估，在指导乳癌患者的治疗决策方面发挥重要作用。这些测试用于肿瘤诊所、医院和研究机构，以深入了解癌症復发的可能性和对辅助治疗的反应。全球乳癌发病率的增加、提高检测准确性的基因组技术的进步以及肿瘤学中个人化医疗方法的日益采用推动了市场成长。

推动市场成长的因素：

全球乳癌復发评分测试市场由几个关键因素推动，包括所有年龄层和种族女性乳癌发生率的上升。下一代定序和多基因表现谱等技术进步有助于完善预后评估和治疗计画。此外，向强调成本效益和客製化治疗策略的基于价值的医疗模式的转变将进一步刺激市场扩张。此外，肿瘤学家、病理学家和分子诊断公司之间的合作推动测试开发和临床验证的创新。

市场限制因素：

儘管成长前景广阔，但乳癌復发评分测试市场面临着监管复杂性、地区偿付差异以及基因组检测广泛临床验证需求等挑战。检测结果和解释的可变性以及基因检测技术的高成本是在资源有限的环境中广泛使用的障碍。应对这些挑战需要持续投资临床研究、测试方案标准化以及倡导癌症护理中基因组测试的保险覆盖范围。

市场机会：

由于生物资讯学的进步、遗传资料库资源的扩大以及医疗保健专业人员对肿瘤学基因组测试临床实用性的认识不断提高，乳癌復发评分测试市场提供了巨大的成长机会。人工智慧和机器学习演算法的整合用于预测建模，再加上患者参与策略，可以提高诊断准确性和治疗结果。此外，标靶治疗伴随诊断的出现和分散测试平台的开发日益增加可及性和患者便利性。

本报告解决的关键问题

  • 推动全球乳癌復发评分测试市场成长的关键因素是什么？
  • 哪些类型的復发评分测试和基因分析技术在肿瘤学实践中越来越受到重视？
  • 技术进步如何改变乳癌復发评分测试市场的竞争格局？
  • 谁是乳癌復发评分测验市场的主要参与者？
  • 全球乳癌復发评分测试市场的新趋势和未来前景如何？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包含/排除

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第4章 增值见解

  • 产品采用率分析
  • 产品 USP/特点
  • 各国的监理状况
  • 近期产品核准/发布
  • 疾病流行病学
  • PESTLE分析
  • 价值链分析
  • 未满足的需求

第5章 市场背景

  • 宏观经济因素
  • 预测因子 - 相关性和影响
  • 市场动态

第6章 全球市场需求（单位）分析

  • 2019-2023年过去的市售（单位）分析
  • 2024-2033年当前及未来市场数量（单位）预测
    • 年成长趋势分析

第7章 世界市场 - 价格分析

  • 区域价格分析：依产品分类
  • 世界平均价格分析基准
  • 定价假设

第8章 全球市场需求（金额或规模，百万美元）分析

  • 2019-2023年过去的市值（百万美元）分析
  • 2024-2033年当前及未来市场规模（百万美元）预测
    • 年成长趋势分析
    • 绝对数量机会分析
  • 利润机会情境 - 趋势/保守/乐观

第9章 世界市场分析：依产品

  • 简介/主要发现
  • 2019-2023年历史市场规模（百万美元）和数量（单位）分析：依产品
  • 2024-2033年当前和未来市场规模（百万美元）和数量（单位）的分析和预测：依产品
    • 测试套件
    • 试剂/消耗品
  • 市场吸引力分析：依产品分类

第10章 全球市场分析：依适应症

  • 简介/主要发现
  • 2019-2023年历史市场规模（百万美元）分析：依适应症
  • 2024-2033年当前和未来市场规模分析和预测（百万美元）：依适应症
    • 1 期乳癌
    • 2 期乳癌
    • 雌激素受体阳性癌症
    • 淋巴结阴性癌症
  • 市场吸引力分析：依适应症

第11章 世界市场分析：依最终使用者

  • 简介/主要发现
  • 2019-2023年历史市场规模分析（百万美元）：依最终使用者
  • 2024-2033年当前和未来市场规模（百万美元）的分析和预测：依最终使用者
    • 医院
    • 专科癌症中心
    • 诊断中心
    • 癌症研究所
  • 市场吸引力分析：依最终用户

第12章 世界市场分析：依地区

  • 简介/主要发现
  • 2019-2023年历史市场规模（百万美元）及数量（单位）分析：依地区
  • 2024-2033年当前和未来市场规模（百万美元）和数量（单位）分析和预测：依地区
    • 北美
    • 拉丁美洲
    • 欧洲
    • 南亚
    • 东亚
    • 大洋洲
    • 中东、非洲
  • 市场吸引力分析：依地区

第13章 北美市场分析

第14章 拉丁美洲市场分析

第15章 欧洲市场分析

第16章 东亚市场分析

第17章 南亚市场分析

第18章 大洋洲市场分析

第19章 中东、非洲市场分析

第20章 市场结构分析

  • 市场分析：依公司层级
  • 主要企业市占率分析（%）
  • 市场现况分析

第21章 竞争分析

  • 竞争对手仪表板
  • 主要发展分析
  • 品牌与推广策略：主要公司
  • 竞争详情
    • Exact Sciences（Genome Health Inc.）
    • NanoString Technologies, Inc.
    • Foundation Medicine, Inc
    • ThermoFisher Scientific
    • Illumina, Inc
    • Hologic Inc（Biotheranostic）
    • Biocartis
    • Roche Diagnostics
    • Epic Sciences
    • Qiagen
    • Abbott
    • Myriad Genetics, Inc
    • Guardant Health

第22章 使用的先决条件与缩写

第23章 研究方法

简介目录
Product Code: PMRREP32146

Persistence Market Research has recently released a comprehensive report on the global Breast Recurrence Score Test Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Breast Recurrence Score Test Market Size (2024E): USD 259 Million
  • Projected Market Value (2033F): USD 576.6 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 9.3%

Breast Recurrence Score Test Market - Report Scope:

The Breast Recurrence Score Test plays a crucial role in guiding treatment decisions for breast cancer patients, providing personalized risk assessment based on genetic profiling of tumor tissue. These tests are utilized in oncology clinics, hospitals, and research institutions, offering insights into the likelihood of cancer recurrence and response to adjuvant therapies. Market growth is driven by increasing incidence of breast cancer globally, advancements in genomic technologies enhancing test accuracy, and growing adoption of personalized medicine approaches in oncology.

Market Growth Drivers:

The global Breast Recurrence Score Test Market is propelled by several key factors, including the rising prevalence of breast cancer among women of all ages and ethnicities. Technological advancements, such as next-generation sequencing and multi-gene expression profiling, contribute to refining prognostic assessments and treatment planning. Moreover, the shift towards value-based healthcare models emphasizing cost-effective and tailored treatment strategies further stimulates market expansion. Additionally, collaborative efforts between oncologists, pathologists, and molecular diagnostic companies drive innovation in test development and clinical validation.

Market Restraints:

Despite promising growth prospects, the Breast Recurrence Score Test Market faces challenges related to regulatory complexities, reimbursement disparities across regions, and the need for extensive clinical validation of genomic assays. Variability in test results and interpretation, as well as the high cost of genetic testing technologies, pose barriers to widespread adoption in resource-limited settings. Addressing these challenges requires continuous investment in clinical research, standardization of testing protocols, and advocacy for insurance coverage of genomic testing in oncology practice.

Market Opportunities:

The Breast Recurrence Score Test Market presents significant growth opportunities driven by advancements in bioinformatics, expanded genetic database resources, and increasing awareness among healthcare professionals about the clinical utility of genomic testing in oncology. Integration of artificial intelligence and machine learning algorithms for predictive modeling, coupled with patient engagement strategies, enhances diagnostic accuracy and treatment outcomes. Furthermore, the emergence of companion diagnostics for targeted therapies and the development of decentralized testing platforms enhance accessibility and patient convenience.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Breast Recurrence Score Test Market globally?
  • Which types of recurrence score tests and genetic profiling technologies are gaining prominence in oncology practice?
  • How are technological advancements reshaping the competitive landscape of the Breast Recurrence Score Test Market?
  • Who are the key players contributing to the Breast Recurrence Score Test Market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global Breast Recurrence Score Test Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Breast Recurrence Score Test Market, including XYZ Genomics, ABC Diagnostics, and PQR Laboratories, focus on innovation, clinical validation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop novel biomarkers, enhance assay sensitivity, and expand testing capabilities across different breast cancer subtypes. Collaborations with oncologists, academic institutions, and patient advocacy groups facilitate market penetration and drive clinical adoption of genomic testing solutions. Moreover, emphasis on data transparency, patient privacy, and regulatory compliance underscores commitment to quality and ethical practice in the evolving oncology diagnostics landscape.

Key Companies Profiled:

  • Exact Sciences (Genome Health Inc.)
  • NanoString Technologies, Inc.
  • Foundation Medicine, Inc
  • ThermoFisher Scientific
  • Illumina, Inc
  • Hologic Inc (Biotheranostic)
  • Biocartis
  • Roche Diagnostics
  • Epic Sciences
  • Qiagen
  • Abbott
  • Myriad Genetics, Inc.
  • Guardant Health

Key Segments of Breast Recurrence Score Test Industry Research

Product:

  • Test Kits
  • Reagents & Consumables

Indication:

  • Stage 1 Breast Cancer
  • Stage 2 Breast Cancer
  • Estrogen-Receptor-Positive Cancer
  • Lymph-Node-Negative Cancer

End User:

  • Hospitals
  • Specialty Cancer Centers
  • Diagnostic Centers
  • Cancer Research Institutions

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4.Value Added Insights

  • 4.1. Product Adoption Analysis
  • 4.2. Product USPs/Features
  • 4.3. Regulatory Landscape, By Country
  • 4.4. Recent Product Approval/Launches
  • 4.5. Disease Epidemiology
  • 4.6. PESTLE Analysis
  • 4.7. Value Chain Analysis
  • 4.8. Unmet Needs

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global Healthcare Expenditure Outlook
    • 5.1.2. Global Life Science Market Outlook
    • 5.1.3. Global Breast Cancer Diagnostics Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising Prevalence of Breast Cancer
    • 5.2.2. Increase in Research and Development
    • 5.2.3. Strategic Collaborations among players
    • 5.2.4. Cost of Product
    • 5.2.5. Adoption Rate
    • 5.2.6. Frequency of Product Approval
    • 5.2.7. Government Initiative
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. Global Market Demand Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 6.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market - Pricing Analysis

  • 7.1. Regional Pricing Analysis By Product
  • 7.2. Global Average Pricing Analysis Benchmark
  • 7.3. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 8.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 8.2. Current and Future Market Size (US$ Mn) Projections, 2024-2033
    • 8.2.1. Y-o-Y Growth Trend Analysis
    • 8.2.2. Absolute $ Opportunity Analysis
  • 8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 9.3.1. Test Kits
    • 9.3.2. Reagents & Consumables
  • 9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2033
    • 10.3.1. Stage 1 Breast Cancer
    • 10.3.2. Stage 2 Breast Cancer
    • 10.3.3. Estrogen-receptor Positive Cancer
    • 10.3.4. Lymph-node Negative Cancer
  • 10.4. Market Attractiveness Analysis By Indication

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Hospitals
    • 11.3.2. Specialty Cancer Centers
    • 11.3.3. Diagnostic Centers
    • 11.3.4. Cancer Research Institutions
  • 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. South Asia
    • 12.3.5. East Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction / Key Findings
  • 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis By Region
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Indication
    • 13.4.4. By End User
  • 13.5. Market trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Indication
        • 13.8.1.2.3. By End User
    • 13.8.2. Canada Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Indication
        • 13.8.2.2.3. By End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction / Key Findings
  • 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Brazil
      • 14.3.1.2. Mexico
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis By Region
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By End User
  • 14.5. Market trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Brazil Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By End User
    • 14.8.2. Mexico Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By End User
    • 14.8.3. Argentina Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Indication
        • 14.8.3.2.3. Type By End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction / Key Findings
  • 15.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. France
      • 15.3.1.3. Spain
      • 15.3.1.4. Russia
      • 15.3.1.5. Italy
      • 15.3.1.6. BENELUX
      • 15.3.1.7. U.K.
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis By Region
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Indication
    • 15.4.4. By End User
  • 15.5. Market trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Germany Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By End User
    • 15.8.2. France Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By End User
    • 15.8.3. Spain Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. Type By End User
    • 15.8.4. Russia Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Indication
        • 15.8.4.2.3. Type By End User
    • 15.8.5. Italy Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By Indication
        • 15.8.5.2.3. By End User
    • 15.8.6. BENELUX Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By Indication
        • 15.8.6.2.3. By End User
    • 15.8.7. U.K. Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By Indication
        • 15.8.7.2.3. By End User

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction / Key Findings
  • 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis By Region
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By End User
  • 16.5. Market trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By End User
    • 16.8.2. Japan Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By End User
    • 16.8.3. South Korea Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction / Key Findings
  • 17.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Thailand
      • 17.3.1.4. Philippines
      • 17.3.1.5. Malaysia
      • 17.3.1.6. Vietnam
      • 17.3.1.7. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis By Region
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By End User
  • 17.5. Market trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By End User
    • 17.8.2. Indonesia Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By End User
    • 17.8.3. Thailand Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Indication
        • 17.8.3.2.3. By End User
    • 17.8.4. Philippines Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Indication
        • 17.8.4.2.3. By End User
    • 17.8.5. Malaysia Market Analysis
      • 17.8.5.1. Introduction
      • 17.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.5.2.1. By Product
        • 17.8.5.2.2. By Indication
        • 17.8.5.2.3. By End User
    • 17.8.6. Vietnam Market Analysis
      • 17.8.6.1. Introduction
      • 17.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.6.2.1. By Product
        • 17.8.6.2.2. By Indication
        • 17.8.6.2.3. By End User

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction / Key Findings
  • 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis By Region
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Indication
    • 18.4.4. By End User
  • 18.5. Market trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By End User
    • 18.8.2. New Zealand Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By End User

19. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction / Key Findings
  • 19.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. Egypt
      • 19.3.1.4. Israel
      • 19.3.1.5. South Africa
      • 19.3.1.6. Northern Africa
      • 19.3.1.7. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Indication
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis By Region
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Indication
    • 19.4.4. By End User
  • 19.5. Market trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Indication
        • 19.8.1.2.3. By End User
    • 19.8.2. Turkiye Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Indication
        • 19.8.2.2.3. By End User
    • 19.8.3. Egypt Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Product
        • 19.8.3.2.2. By Indication
        • 19.8.3.2.3. By End User
    • 19.8.4. Israel Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Product
        • 19.8.4.2.2. By Indication
        • 19.8.4.2.3. By End User
    • 19.8.5. South Africa Market Analysis
      • 19.8.5.1. Introduction
      • 19.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.5.2.1. By Product
        • 19.8.5.2.2. By Indication
        • 19.8.5.2.3. By End User
    • 19.8.6. Northern Africa Market Analysis
      • 19.8.6.1. Introduction
      • 19.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.6.2.1. By Product
        • 19.8.6.2.2. By Indication
        • 19.8.6.2.3. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players (%)
  • 20.3. Market Presence Analysis
    • 20.3.1. Regional Footprint of Players
    • 20.3.2. Product Footprint of Players
    • 20.3.3. Channel Footprint of Players

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Key Development Analysis
  • 21.3. Branding and Promotional Strategies, By Key Players
  • 21.4. Competition Deep Dive
    • 21.4.1. Exact Sciences (Genome Health Inc.)
      • 21.4.1.1. Overview
      • 21.4.1.2. Product Portfolio
      • 21.4.1.3. Key Financials
      • 21.4.1.4. Sales Footprint
      • 21.4.1.5. SWOT Analysis
      • 21.4.1.6. Strategy Overview
        • 21.4.1.6.1. Marketing Strategies
        • 21.4.1.6.2. Channel Strategies
        • 21.4.1.6.3. Product Strategies
    • 21.4.2. NanoString Technologies, Inc.
      • 21.4.2.1. Overview
      • 21.4.2.2. Product Portfolio
      • 21.4.2.3. Key Financials
      • 21.4.2.4. Sales Footprint
      • 21.4.2.5. SWOT Analysis
      • 21.4.2.6. Strategy Overview
        • 21.4.2.6.1. Marketing Strategies
        • 21.4.2.6.2. Channel Strategies
        • 21.4.2.6.3. Product Strategies
    • 21.4.3. Foundation Medicine, Inc
      • 21.4.3.1. Overview
      • 21.4.3.2. Product Portfolio
      • 21.4.3.3. Key Financials
      • 21.4.3.4. Sales Footprint
      • 21.4.3.5. SWOT Analysis
      • 21.4.3.6. Strategy Overview
        • 21.4.3.6.1. Marketing Strategies
        • 21.4.3.6.2. Channel Strategies
        • 21.4.3.6.3. Product Strategies
    • 21.4.4. ThermoFisher Scientific
      • 21.4.4.1. Overview
      • 21.4.4.2. Product Portfolio
      • 21.4.4.3. Key Financials
      • 21.4.4.4. Sales Footprint
      • 21.4.4.5. SWOT Analysis
      • 21.4.4.6. Strategy Overview
        • 21.4.4.6.1. Marketing Strategies
        • 21.4.4.6.2. Channel Strategies
        • 21.4.4.6.3. Product Strategies
    • 21.4.5. Illumina, Inc
      • 21.4.5.1. Overview
      • 21.4.5.2. Product Portfolio
      • 21.4.5.3. Key Financials
      • 21.4.5.4. Sales Footprint
      • 21.4.5.5. SWOT Analysis
      • 21.4.5.6. Strategy Overview
        • 21.4.5.6.1. Marketing Strategies
        • 21.4.5.6.2. Channel Strategies
        • 21.4.5.6.3. Product Strategies
    • 21.4.6. Hologic Inc (Biotheranostic)
      • 21.4.6.1. Overview
      • 21.4.6.2. Product Portfolio
      • 21.4.6.3. Key Financials
      • 21.4.6.4. Sales Footprint
      • 21.4.6.5. SWOT Analysis
      • 21.4.6.6. Strategy Overview
        • 21.4.6.6.1. Marketing Strategies
        • 21.4.6.6.2. Channel Strategies
        • 21.4.6.6.3. Product Strategies
    • 21.4.7. Biocartis
      • 21.4.7.1. Overview
      • 21.4.7.2. Product Portfolio
      • 21.4.7.3. Key Financials
      • 21.4.7.4. Sales Footprint
      • 21.4.7.5. SWOT Analysis
      • 21.4.7.6. Strategy Overview
        • 21.4.7.6.1. Marketing Strategies
        • 21.4.7.6.2. Channel Strategies
        • 21.4.7.6.3. Product Strategies
    • 21.4.8. Roche Diagnostics
      • 21.4.8.1. Overview
      • 21.4.8.2. Product Portfolio
      • 21.4.8.3. Key Financials
      • 21.4.8.4. Sales Footprint
      • 21.4.8.5. SWOT Analysis
      • 21.4.8.6. Strategy Overview
        • 21.4.8.6.1. Marketing Strategies
        • 21.4.8.6.2. Channel Strategies
        • 21.4.8.6.3. Product Strategies
    • 21.4.9. Epic Sciences
      • 21.4.9.1. Overview
      • 21.4.9.2. Product Portfolio
      • 21.4.9.3. Key Financials
      • 21.4.9.4. Sales Footprint
      • 21.4.9.5. SWOT Analysis
      • 21.4.9.6. Strategy Overview
        • 21.4.9.6.1. Marketing Strategies
        • 21.4.9.6.2. Channel Strategies
        • 21.4.9.6.3. Product Strategies
    • 21.4.10. Qiagen
      • 21.4.10.1. Overview
      • 21.4.10.2. Product Portfolio
      • 21.4.10.3. Key Financials
      • 21.4.10.4. Sales Footprint
      • 21.4.10.5. SWOT Analysis
      • 21.4.10.6. Strategy Overview
        • 21.4.10.6.1. Marketing Strategies
        • 21.4.10.6.2. Channel Strategies
        • 21.4.10.6.3. Product Strategies
    • 21.4.11. Abbott
      • 21.4.11.1. Overview
      • 21.4.11.2. Product Portfolio
      • 21.4.11.3. Key Financials
      • 21.4.11.4. Sales Footprint
      • 21.4.11.5. SWOT Analysis
      • 21.4.11.6. Strategy Overview
        • 21.4.11.6.1. Marketing Strategies
        • 21.4.11.6.2. Channel Strategies
        • 21.4.11.6.3. Product Strategies
    • 21.4.12. Myriad Genetics, Inc
      • 21.4.12.1. Overview
      • 21.4.12.2. Product Portfolio
      • 21.4.12.3. Key Financials
      • 21.4.12.4. Sales Footprint
      • 21.4.12.5. SWOT Analysis
      • 21.4.12.6. Strategy Overview
        • 21.4.12.6.1. Marketing Strategies
        • 21.4.12.6.2. Channel Strategies
        • 21.4.12.6.3. Product Strategies
    • 21.4.13. Guardant Health
      • 21.4.13.1. Overview
      • 21.4.13.2. Product Portfolio
      • 21.4.13.3. Key Financials
      • 21.4.13.4. Sales Footprint
      • 21.4.13.5. SWOT Analysis
      • 21.4.13.6. Strategy Overview
        • 21.4.13.6.1. Marketing Strategies
        • 21.4.13.6.2. Channel Strategies
        • 21.4.13.6.3. Product Strategies

22. Assumptions and Acronyms Used

23. Research Methodology